PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
06-May-2025 Xlife Sciences AG Announces Strategic Collaboration between Portfolio Company Firstgene Life Sciences and Hovione in the Field of Gene Therapy Xlife Sciences AG
06-May-2025 SCHOTT Pharma and Serum Institute of India welcome new partner to Joint Venture in India; TPG makes strategic investment in SCHOTT Poonawalla SCHOTT Pharma AG & Co. KGaA
06-May-2025 Evotec SE reports Q1 2025 results: Paving the way for 2025 growth in soft market environment Evotec SE
05-May-2025 Xlife Sciences AG confirms sustainable value development and strategic scaling of the portfolio in the 2024 Valuation Report Xlife Sciences AG
03-May-2025 Vitruvia Medical AG: Year End results as of December 31,2024 Vitruvia Medical AG
02-May-2025 MEDICLIN increases group operating result in the first quarter of 2025 MEDICLIN AG
02-May-2025 Immunic to Participate in Scientific and Industry Conferences in May Immunic AG
01-May-2025 FDA Grants OKYO Pharma Fast Track Designation to Urcosimod for Neuropathic Corneal Pain OKYO Pharma Limited
01-May-2025 Clinigen announces key executive appointments to drive the next phase of growth and deliver increased investor value Clinigen
01-May-2025 Leqembi® ▼ (lecanemab) proposed Marketing Authorisation Variation for monthly intravenous maintenance dosing for the treatment of early Alzheimer’s disease (AD) in the UK is validated for evaluation by the MHRA Eisai
01-May-2025 Preliminary unaudited results for the year ended 31 December 2024 Commercial progress and order book growth Cambridge Cognition Holdings plc
30-Apr-2025 BRAIN Biotech AG reports preliminary Q2 figures and forecasts a more conservative development for the second half of the fiscal year 2024/25 BRAIN Biotech AG
30-Apr-2025 FamiCord AG continues growth course in 2024 after strong year-end business and stabilizes business development in home market Germany FamiCord AG
30-Apr-2025 Immunic Announces Vidofludimus Calcium Reduced Risk of Disability Worsening by 30% in Primary Progressive Multiple Sclerosis Patients from Phase 2 CALLIPER Trial Immunic AG
30-Apr-2025 Isomerase Enhances Process Innovation Capabilities for Protein Discovery and Production Isomerase
30-Apr-2025 Asklepios Group: Publication of Asklepios CSRD Report 2024 Asklepios Kliniken
30-Apr-2025  Equity (NAV) increases by almost EUR 27 million to EUR 277.9 million, corresponding to EUR 64.90 per share. EBIT increases by EUR 2.75 million to EUR 33.0 million. The equity ratio rises to 95.5%. MPH Health Care AG
30-Apr-2025 Drägerwerk AG & Co. KGaA: Dräger with strong demand in the first quarter of 2025 Drägerwerk AG & Co. KGaA
30-Apr-2025 Strong start in an environment marked by macroeconomic uncertainties Straumann Holding AG
29-Apr-2025 Abivax Announces Completion of Enrollment for the Phase 3 ABTECT Trials in Patients with Moderately to Severely Active Ulcerative Colitis ABIVAX